OBSIDIAN THERAPEUTICS, INC. Common Stock, Capital Shares Reserved for Future Issuance
OBSIDIAN THERAPEUTICS, INC. (OBX) had Common Stock, Capital Shares Reserved for Future Issuance of 5.33 million shares as of 2026-06-30, per its S-1 filed 2026-08-28.
Financial Statements › Notes › Stockholders' Equity Note › Class of Stock Disclosures
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2026-08-28
- 2026-06-30: Common Stock, Capital Shares Reserved for Future Issuance 5.33M shares.
- 2025-12-31: Common Stock, Capital Shares Reserved for Future Issuance 4.48M shares.
- 2024-12-31: Common Stock, Capital Shares Reserved for Future Issuance 1.99M shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance |
|---|---|
| 2026-06-30 | 5.33M shares S-1 · filed 2026-08-28 |
| 2025-12-31 | 4.48M shares S-1 · filed 2026-08-28 |
| 2024-12-31 | 1.99M shares S-1 · filed 2026-08-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |